The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome

Prenatal Diagnosis

Volumn 22, Issue 5, 2002, Pages 385-387

  Christiansen, Michael ^a   Hgdall, Estrid V ^a   Larsen, Severin O ^a,b   Hgdall, Claus ^a,c  

^a STATENS SERUM INSTITUT   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Likelihood ratio; Maternal serum screening; Prenatal diagnosis

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LABORATORY; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; RISK; SECOND TRIMESTER PREGNANCY; STATISTICAL MODEL;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; ESTRIOL; FEMALE; GESTATIONAL AGE; HUMANS; LIKELIHOOD FUNCTIONS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

EID: 18444411003     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.297     Document Type: Article

References (12)

1. Prenatal screening for neural tube defects, quality specification of maternal serum alpha-fetoprotein analysis
2. The accuracy of assigned risks in maternal serum screening
3. False-negative results in Down's syndrome screening
4. Precision of risk estimates in multidimensional likelihood ratio based screening with Down's syndrome as a special case
5. Repeat maternal serum testing in multiple marker Down's syndrome screening programmes
6. Software for prenatal Down syndrome risk calculation: A comparative study of six software packages
7. Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan
8. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
9. Empirical validation of risk screening for Down's syndrome
10. Antenatal screening for Down's syndrome
11. Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's syndrome screening